【Introduction】
"Do ordinary people use new drugs that are burned with money?"
Artificial intelligence medicine will take another 150 million US dollars, and the burning money cannot be stopped
Last week, Ittizer received $150 million in financing led by China Renaissance Capital, becoming another new drug unicorn.
As the world's first AI-driven drug delivery and formulation development start-up company, Itai Pharmaceutical realizes the automation and intelligence of drug delivery and formulation development through the combination of high-throughput test platform and artificial intelligence computing technology.
Compared with the traditional AI-assisted new drug discovery, Futai has gone further and is committed to promoting the development of AI drug and delivery system platforms, and now there are many products that have advanced to the clinical phase III stage, and clinical products are a high threshold for new drug companies.
Now an important premise for new drug companies to get financing is that there are a large number of powerful executives, from the R & D leaders of international pharmaceutical giants to the well-known alumni of Ivy League universities in the United States, and now the team of Agent Tai includes academician Chen Hongmin of the American College of Engineering, Dr. Caida Lai, Dr. Wang Wenshou and a number of MIT scientists.
Hongmin Chen is a successful entrepreneur with excellent drug research and development capabilities, she holds a bachelor's degree in chemical engineering from the University of Texas at Austin, a master's degree in chemical engineering and a doctorate in science from the Massachusetts Institute of Technology, and served as the chief scientific officer of Kala Pharmaceuticals, successfully advancing a new nanoparticle technology from the experimental discovery stage to the phase III clinical trial stage, and obtained FDA approval. She helped found TransForm Pharmaceuticals, which was acquired by Johnson & Johnson in 2005.
Phastech has created a new track of artificial intelligence in drug delivery, with the self-developed drug delivery "high-throughput experimental platform" combined with data-driven "AI algorithm" and mechanism-driven "quantum chemistry and molecular dynamics simulation", predicting the physicochemical and biological characteristics of small molecules and nucleic acid drugs in a specific microenvironment, using AI-driven dry and wet experiment iterations, to achieve more effective pilot optimization, nucleic acid sequence design and optimization, etc., more importantly, there is an advanced drug delivery system, which can be accurately delivered.
After alphafold came out, it set off a wave of artificial intelligence-assisted research and development, bringing new hope to many patients without treatment options, but there is still a long way to go from the laboratory to the clinic.
Huamei Xingtai, mobile energy storage is a good business in China
Huamei Xingtai, a provider of home and outdoor energy storage technology, completed its Series B financing last week, led by Qianhai Fund of Funds and Zhuoyuan Capital.
Energy storage technology refers to the storage of energy, the use of technology when needed, energy storage technology will be more difficult to store the form of energy, into a technically easier and lower cost form of storage. For example, solar water heaters store light energy in hot water, and batteries store electrical energy in electrochemical energy.
Generally, when the proportion of renewable energy generation is low, such as less than 20%, the load in the original grid as a peak power regulation follows the power plant, which can cope with the change in the power supply of intermittent renewable energy. However, when the proportion is high to a certain extent, there is a need for additional adjustable systems to maintain the power supply balance.
The previous energy storage technology, mostly large-scale, was used to help balance the staggered peak electricity consumption, and now with the improvement of energy storage efficiency and cost reduction, more and more individual users have begun to use energy storage equipment, and home and outdoor energy storage have become a hot track.
Huamei Xingtai's core customers include Wal-Mart in the United States and Lidl in Germany, known as Europe 7-11, although it is mainly OEM, but the company has established a complete supply chain manufacturing and research and development system from ternary and lithium iron phosphate batteries, BMS, inverters, etc., laying a good foundation for the expansion of products.
Photovoltaic market in the context of low-carbon zero carbon, also began the second spring, distributed photovoltaic large-scale rollout, but also for the light storage has brought opportunities, in addition to consolidating the existing outdoor energy storage products FOUNDRY business, optical storage integrated energy will be the next important direction of Huamei Xingtai. Musk on the other side of the ocean has also launched a variety of power generation and energy storage products early, and Powerwall and Megapack have begun to attack the city in the world.
One-week financing summary
Last week, a total of 16 investment and financing incidents occurred in the domestic biomedicine and artificial intelligence fields, with a total financing amount of 100 million yuan for 2 artificial intelligence and 14 financing for biomedicine with a total amount of 2.8 billion yuan.
The A round of financing projects are the most, there are 5, there is a successful IPO listing, Tianyi Medical in the field of biomedicine, last week's financing projects as a whole are few, but the financing heat in the field of biomedicine is still much higher than artificial intelligence.
Last week, the most financing was Ptex Pharmaceutical, raising 150 million US dollars, equivalent to 956 million yuan, 184 million yuan higher than the IPO-listed Tianyi Medical, and it remains to be seen whether the IPO-listed Tianyi Medical, which focuses on artificial intelligence new drug research and development, can really land.
Weekly Financing Summary: